Cargando...
Pregabalin add‐on for drug‐resistant focal epilepsy
BACKGROUND: Epilepsy is a common neurological disease that affects approximately 1% of the UK population. Approximately one‐third of these people continue to have seizures despite drug treatment. Pregabalin is one of the newer antiepileptic drugs which have been developed to improve outcomes. This i...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2019
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6614921/ https://ncbi.nlm.nih.gov/pubmed/31287157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005612.pub4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|